Rochester, New York 12/15/2009 10:30:00 AM
News / Business

Encore Energy (PKS: ENCS) Completes LOI to Acquire H2One Hydrogen Injection Line of Products

Encore Energy Systems (PINKSHEETS: ENCS) recently announced that it has completed a Letter of Intent to acquire the exclusive distribution rights to the proprietary H2One line of Hydrogen Injection Products. The innovative H2One Product line of high-performance, on-board hydrogen electrolyser splits distilled water into hydrogen and oxygen, then injects those gases directly into the air intake of the engine.

 

MicroCap Insider is a web-based financial portal.

Sign Up for our Free Stock Newsletter

MicroCap Insider publishes a free penny stock newsletter providing stock alerts on companies positioned to deliver high-yield gains to investors.

 

Current products, that will be available for immediate shipping upon finalization of the LOI, target the transport and commercial trucking industries. Investors will receive further updates regarding the finalization of the Letter of Intent and product availability. Encore specializes in alternative energy and environmentally friendly power production. It is an international aggregator of biofuel reactor technology, biofuel distribution, and biofuel production facilities. The company supplies biofuel-based stationary power generators and an array of solar technologies and products. The Company owns the patents for the use of grey-water and domestic water in geothermal heat exchanger systems. The Company licenses its patented technology to other energy-related businesses.

 

Sign Up for FREE. Investors interested in receiving small cap stock alerts through the penny stock newsletter published by MicroCap Insider can sign up for free by visiting our website.

 

About Us

 

MicroCap Insider is a leading penny stock web site with extensive experience in the OTC market, providing top stock picks, investing tips and exclusive research on small cap stocks on the verge of producing large financial gains.

 

Please click here to read the full disclaimer.